Safety and efficacy of personalised versus standard dosing of linezolid in patients with sepsis (SePkLin): a pragmatic, multicentre, randomised, controlled and superiority clinical trial protocol
Authors
Eva Rial‐Pensado (ORCID: https://orcid.org/0000-0002-2645-6626)
Safety and efficacy of personalised versus standard dosing of linezolid in patients with sepsis (SePkLin): a pragmatic, multicentre, randomised, controlled and superiority clinical trial protocol
Eva Rial‐Pensado, Luís Valdés, María Sandra Albiñana Pérez, Gema Barbeito‐Castiñeiras et al.
Citations
1 citations
Journal
BMJ Open
Topics
Antibiotics Pharmacokinetics and Efficacy
Field-Weighted Citation Impact (FWCI)
0.45
article
Safety and efficacy of personalised versus standard dosing of linezolid in patients with sepsis (SePkLin): a pragmatic, multicentre, randomised, controlled and superiority clinical trial protocol
Eva Rial‐Pensado, Luís Valdés, María Sandra Albiñana Pérez, Gema Barbeito‐Castiñeiras, Anxo Fernández‐Ferreiro, Ana Estany‐Gestal, Manuel Taboada, Pedro Rascado Sedes, Teresa Cabaleiro, Cristina Mondelo‐García, Irene Zarra‐Ferro, Iria Varela-Rey, Jorge Arca-Suárez, Ana Castro‐Balado, Francisco Cajade-Pascual, Enrique Bandín‐Vilar, STRATA Collaboration Group, Álvaro Mena de, Antonio Pose‐Reino, María Teresa Rey-Rilo, Enrique Alemparte-Pardavila, María Teresa Rodríguez-Jato
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 14(10)
Institutions
Universidade da Coruña (ES), Universidade de Santiago de Compostela (ES), Xunta de Galicia (ES), Instituto de Salud Carlos III (ES), Conselleria de Sanitat Universal i Salut Pública (ES), Complejo Hospitalario Universitario de Santiago (ES), Complexo Hospitalario Universitario A Coruña (ES), Servicio Gallego de Salud (ES), Instituto de Investigación Biomédica de A Coruña (ES)
Funders
European Commission, Xunta de Galicia, Spanish Clinical Research Network, Instituto de Salud Carlos III, European Social Fund